Subscribe to View from the Top
[X] close

Subscribe to be notified each week when the latest View from the Top becomes available.


*Indicates a required field



Note: The input below should not be filled in. It is a spam trap. Please ignore it. If you populate this input, the form will return an error.
Brought to you by
BIOCOM Phase 3 Digital

Daniel M. Bradbury, Amylin Pharmaceuticals

You need to upgrade your Flash Player
  • Type:  Full Episode
  • Company:  Amylin Pharmaceuticals
  • Speaker(s):  Daniel M. Bradbury, President and CEO of Amylin Pharmaceuticals, Chairman of BIOCOM
  • Description:  Daniel M. Bradbury discusses the impact of the FDA approval process on innovation, as well as the potential of stem cell research.

Top Sponsors


Available Sponsorships

  • Video Roll Ins
  • Specific Video Page Banner Ads
  • Homepage Banner Ads
  • Sitewide Banner Ads
Contact Us About Sponsorship Opportunities